Refractory celiac disease (RCD) is a complex autoimmune disorder much like the more common celiac disease but, unlike celiac disease, it is resistant or unresponsive to at least 12 months of treatment...
Comprehensive, easy-to-understand information about this condition
How we create this content →Report Generation Failed
We couldn't automatically generate the report. This may be due to temporary service issues.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
Organizations with orphan designations or approved therapies for this disease
Amgen Inc
Other
Bristol-Myers Squibb Pharmaceutical Research Institute
Other
Glaukos Corporation
Other
IOP Inc.
Other
Medtronic, Inc.
Other
Metacel Pharmaceuticals, LLC
Other
Osmotica Pharmaceutical Corp.
Other
Sorrento Theraeputics, Inc.
Other